Zydus Cadila gets DCGI nod for phase III trials of its COVID-19 vaccine candidate
NE HEALTH BUREAU NEW DELHI, JAN 3 The Drugs Controller General of India (DCGI) has approved conducting phase III trials ...
NE HEALTH BUREAU NEW DELHI, JAN 3 The Drugs Controller General of India (DCGI) has approved conducting phase III trials ...
